Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,640,952
+$1,566,562 QoQ
Shares Held
246,818
+153.6% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#20
of 131 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Derivatives in KROS
reported options exposure · as of Sep 30, 2024CallValue
$17,421
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. KROS ranks #101 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
|
457,907 | $39,009,097 |
All Filings in KROS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,640,952 | 246,818 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,074,390 | 97,318 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $383,806 | 18,851 | Shares | Sole | 2026-02-18 | |
| 2025-10-15 | $0 | 0 | Shares | Sole | 2025-10-15 | |
| 2025-09-30 | $85,258,156 | 5,389,264 | Shares | Sole | 2025-11-14 | |
| 2025-08-21 | $81,755,134 | 5,389,264 | Shares | Sole | 2025-08-21 | |
| 2025-06-30 | $71,946,674 | 5,389,264 | Shares | Sole | 2025-08-14 | |
| 2025-05-12 | $74,071,845 | 5,390,964 | Shares | Sole | 2025-05-12 | |
| 2025-05-08 | $75,581,315 | 5,390,964 | Shares | Sole | 2025-05-08 | |
| 2025-04-24 | $77,737,700 | 5,390,964 | Shares | Sole | 2025-04-28 | |
| 2025-04-04 | $53,801,820 | 5,390,964 | Shares | Sole | 2025-04-11 | |
| 2025-03-31 | $15,147,037 | 1,486,461 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $367,984 | 23,246 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,421 | 300 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $25,845,098 | 445,068 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,085,461 | 548,916 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $22,391,686 | 338,243 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,367,444 | 688,316 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||